Quality improvement initiatives in the care and prevention of fragility fractures in the Asia Pacific region
- PMID: 35987919
- PMCID: PMC9392505
- DOI: 10.1007/s11657-022-01153-2
Quality improvement initiatives in the care and prevention of fragility fractures in the Asia Pacific region
Abstract
This narrative review summarises ongoing challenges and progress in the care and prevention of fragility fractures across the Asia Pacific region since mid-2019. The approaches taken could inform development of national bone health improvement Road Maps to be implemented at scale during the United Nations 'Decade of Healthy Ageing'.
Purpose: This narrative review summarises recent studies that characterise the burden of fragility fractures, current care gaps and quality improvement initiatives intended to improve the care and prevention of fragility fractures across the Asia Pacific region.
Methods: The review focuses on published studies, reports and quality improvement initiatives undertaken during the period July 2019 to May 2022.
Results: Epidemiological studies conducted in countries and regions throughout Asia Pacific highlight the current and projected increasing burden of fragility fractures. Recent studies and reports document a persistent and pervasive post-fracture care gap among people who have sustained fragility fractures. Global initiatives developed by the Fragility Fracture Network and International Osteoporosis Foundation have gained significant momentum in the Asia Pacific region, despite the disruption caused by the COVID-pandemic. The Asia Pacific Fragility Fracture Alliance has developed educational resources including a Hip Fracture Registry Toolbox and a Primary Care Physician Education Toolkit. The Asia Pacific Osteoporosis and Fragility Fractures Society-a new section of the Asia Pacific Orthopaedic Association-is working to engage orthopaedic surgeons across the region in the care and prevention of fragility fractures. The Asia Pacific Consortium on Osteoporosis developed a framework to support national clinical guidelines development groups. Considerable activity at the national level is evident in many countries across the region.
Conclusion: Development and implementation of national Road Maps informed by the findings of this review are urgently required to respond to the epidemiological emergency posed by fragility fractures during the United Nations 'Decade of Healthy Ageing'.
Keywords: Fracture liaison service; Fragility fracture; Orthogeriatrics; Osteoporosis; Systematic approach.
© 2022. International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation.
Conflict of interest statement
Adjunct Associate Professor Paul James Mitchell (PJM) has undertaken consultancy for governments, national and international osteoporosis societies, healthcare professional organisations and private sector companies relating to systematic approaches to fragility fracture care, and prevention since 2005. PJM is a paid consultant and project manager for the Asia Pacific Fragility Fracture Alliance. Adjunct Assistant Professor Seng Bin Ang has no disclosures relating to this work. Professor Leilani Basa Mercado-Asis reports no conflicts of interest. Professor Reynaldo Rey-Matias has no disclosures relating to this work. Professor Wen-Shiang Chen has no disclosures relating to this work. Professor Leon Flicker reports no conflicts of interest. Dr. Edward Leung has no disclosures relating to this work. Professor David Choon has no disclosures relating to this work. Dr. Sankara Kumar Chandrasekaran has no disclosures relating to this work. Professor Jacqueline Clare Therese Close has no disclosures relating to this work. Dr. Hannah Seymour has no disclosures relating to this work. Professor Cyrus Cooper has received consulting fees and honoraria from Amgen, Danone, Eli Lilly, GSK, Medtronic, Merck, Nestle, Novartis, Pfizer, Roche, Servier, Shire, Takeda and UCB. Dr. Philippe Halbout is the Chief Executive Officer of the International Osteoporosis Foundation and has no disclosures relating to this work. Professor Robert Daniel Blank: Consulting, Bristol Myers Squibb; advisory board, Amgen; ownership, Abbott Labs, Abbvie, Amgen, JangoBio, Procter & Gamble; editorial stipend, Elsevier; authorship royalties, Wolters Kluwer. Dr. Yanling Zhao reports no conflicts of interest. Professor Jae-Young Lim reports no disclosures relating to this work. Associate Professor Irewin Tabu reports no disclosures relating to this work. Professor Maoyi Tian reports no conflicts of interest. Professor Aasis Unnanuntana has no disclosures relating to this work. Assistant Professor Ronald Man Yeung Wong has no disclosures relating to this work. Professor Noriaki Yamamoto has no disclosures relating to this work. Professor Ding-Chen (Derrick) Chan reports personal fees (consulting fees) from Amgen, Lotus, Eli-Lilly and Harvester Trading Co, Ltd. Dato’ Dr. Joon Kiong Lee has received honoraria from Amgen, Mylan, and Zuellig Pharma for speaking at symposia, as member of advisory board and educational programmes and workshops.
Figures
References
-
- Wikipedia (2022) World population. https://en.wikipedia.org/wiki/World_population. Accessed 16 Aug 2022
-
- World Health Organization (2020) The decade of healthy ageing: a new UN-wide initiative. https://www.who.int/news/item/14-12-2020-decade-of-healthy-ageing-a-new-.... Accessed 16 Aug 2022
-
- Worldometers.info (2022) Current world population. https://www.worldometers.info/world-population/. Accessed 16 Aug 2022
-
- Wikipedia (2022) List of countries and dependencies by population. https://en.wikipedia.org/wiki/List_of_countries_and_dependencies_by_popu.... Accessed 16 Aug 2022
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
